Abbvie Inc. vs ResMed Inc.
ABBV vs RMD — side-by-side comparison from reported financials. ABBV leads 5, RMD leads 6 of 11 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
ResMed Inc.
RMD · Healthcare
$230.05+1.46%Mixed
| Metric | ABBV | RMD |
|---|---|---|
| Price | $276.43 | $230.05 |
| Market cap | $488B | $32.4B |
| Revenue (TTM) | $64.4B | $5.65B |
| Revenue growth | +1.8% | +10.2% |
| Net margin | 9.8% | 26.9% |
| Free cash flow | $18.2B | $1.65B |
| Net cash (debt) | ($56.2B) | $643M |
| 1-year price return | +19.8% | -17.2% |
| P/E | 77.4 | 21.2 |
| P/E vs own history (cheap-side %) | 23% | 91% |
| Dividend yield | 2.45% | 1.08% |
| Return on equity | 96% | 24% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 11,370 |
Full résumé-style profiles: ABBV CV · RMD CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.